ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,263,070 | -18.7% | 16,810 | -17.3% | 0.02% | -17.2% |
| Q4 2022 | $7,703,508 | -40.0% | 20,335 | -44.1% | 0.03% | -38.3% |
| Q3 2022 | $12,833,000 | +31.8% | 36,350 | +41.4% | 0.05% | +14.6% |
| Q2 2022 | $9,739,000 | +1319.7% | 25,704 | +1081.2% | 0.04% | +1266.7% |
| Q1 2022 | $686,000 | -70.9% | 2,176 | -67.7% | 0.00% | -66.7% |
| Q4 2021 | $2,360,000 | +76.4% | 6,739 | +52.1% | 0.01% | +80.0% |
| Q3 2021 | $1,338,000 | +199.3% | 4,430 | +198.1% | 0.01% | +150.0% |
| Q2 2021 | $447,000 | – | 1,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |